FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henri Gozlan

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Autoradiography

Occupations

Electrophysiology

Co-author Network

Publications

TOP 3
Pascale Paule Quilichini; Dennis A Turner; Aurélie Carabalona; monique Esclapez; Henri Gozlan; Anton Ivanov; Michel Le Van Quyen; Christophe Bernard
Hub GABA neurons mediate gamma-frequency oscillations at ictal-like event onset in the immature hippocampus.
Pascale Paule Quilichini; Catherine Chiron; Yehezkel Ben-Ari; Henri Gozlan
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.
Ilgam Khalilov; Michel Le Van Quyen; Henri Gozlan; Yehezkel Ben-Ari
Epileptogenic actions of GABA and fast oscillations in the developing hippocampus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henri Gozlan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Pascale Paule Quilichini; Dennis A Turner; Aurélie Carabalona; monique Esclapez; Henri Gozlan; Anton Ivanov; Michel Le Van Quyen; Christophe Bernard
Hub GABA neurons mediate gamma-frequency oscillations at ictal-like event onset in the immature hippocampus.
Neuron 2012;74(1):57-64.
2006: Pascale Paule Quilichini; Catherine Chiron; Yehezkel Ben-Ari; Henri Gozlan
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.
Epilepsia 2006;47(4):704-16.
2005: Ilgam Khalilov; Michel Le Van Quyen; Henri Gozlan; Yehezkel Ben-Ari
Epileptogenic actions of GABA and fast oscillations in the developing hippocampus.
Neuron 2005;48(5):787-96.
2005: Christophe Bernard; Mathieu Milh; Y M Morozov; Yehezkel Ben-Ari; T F Freund; Henri Gozlan
Altering cannabinoid signaling during development disrupts neuronal activity.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9388-93.
2004: Yehezkel Ben-Ari; Ilgam Khalilov; Alfonso Represa; Henri Gozlan
Interneurons set the tune of developing networks.
Trends in neurosciences 2004;27(7):422-7.
2003: Pascale Paule Quilichini; Diabé Diabira; Catherine Chiron; Mathieu Milh; Yehezkel Ben-Ari; Henri Gozlan
Effects of antiepileptic drugs on refractory seizures in the intact immature corticohippocampal formation in vitro.
Epilepsia 2003;44(11):1365-74.
2002: Pascale Paule Quilichini; Diabé Diabira; Catherine Chiron; Yehezkel Ben-Ari; Henri Gozlan
Persistent epileptiform activity induced by low Mg2+ in intact immature brain structures.
The European journal of neuroscience 2002;16(5):850-60.
2002: Sonia Hennou; Ilgam Khalilov; Diabé Diabira; Yehezkel Ben-Ari; Henri Gozlan
Early sequential formation of functional GABA(A) and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus.
The European journal of neuroscience 2002;16(2):197-208.
2001: Jean-Luc Gaiarsa; Ilgam Khalilov; Henri Gozlan; Yehezkel Ben-Ari
Morphology of CA3 non-pyramidal cells in the developing rat hippocampus.
Brain research. Developmental brain research 2001;127(2):157-64.
1999: Roman Tyzio; Alfonso Represa; Isabel Jorquera; Yehezkel Ben-Ari; Henri Gozlan; Laurent Aniksztejn
The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(23):10372-82.
1999: Diabé Diabira; Sonia Hennou; N Chevassus-Au-Louis; Yehezkel Ben-Ari; Henri Gozlan
Late embryonic expression of AMPA receptor function in the CA1 region of the intact hippocampus in vitro.
The European journal of neuroscience 1999;11(11):4015-23.
1998: V Crépel; P Congar; Laurent Aniksztejn; Henri Gozlan; C Hammond; Yehezkel Ben-Ari
Synaptic plasticity in ischemia: role of NMDA receptors.
Progress in brain research 1998;116():273-85.
1997: C Debray; Diabé Diabira; Jean-Luc Gaiarsa; Yehezkel Ben-Ari; Henri Gozlan
Contributions of AMPA and GABA(A) receptors to the induction of NMDAR-dependent LTP in CA1.
Neuroscience letters 1997;238(3):119-22.
1996: June C Hirsch; O Quesada; monique Esclapez; Henri Gozlan; Yehezkel Ben-Ari; C L Bernard
Enhanced NMDAR-dependent epileptiform activity is controlled by oxidizing agents in a chronic model of temporal lobe epilepsy.
Journal of neurophysiology 1996;76(6):4185-9.
1995: Henri Gozlan; Y Ben-Ari
NMDA receptor redox sites: are they targets for selective neuronal protection?
Trends in pharmacological sciences 1995;16(11):368-74.
1995: Henri Gozlan; Rustem Khazipov; Diabé Diabira; Yehezkel Ben-Ari
In CA1 hippocampal neurons, the redox state of NMDA receptors determines LTP expressed by NMDA but not by AMPA receptors.
Journal of neurophysiology 1995;73(6):2612-7.
1995: Henri Gozlan; Rustem Khazipov; Yehezkel Ben-Ari
Multiple forms of long-term potentiation and multiple regulatory sites of N-methyl-D-aspartate receptors: role of the redox site.
Journal of neurobiology 1995;26(3):360-9.
1995: Henri Gozlan; S Thibault; AM Laporte; L Lima; Michel Hamon
The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
European journal of pharmacology 1995;288(2):173-86.
1994: AM Laporte; L Lima; Henri Gozlan; Michel Hamon
Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
European journal of pharmacology 1994;271(2-3):505-14.
1994: Henri Gozlan; Diabé Diabira; P Chinestra; Yehezkel Ben-Ari
Anoxic LTP is mediated by the redox modulatory site of the NMDA receptor.
Journal of neurophysiology 1994;72(6):3017-22.
1994: Henri Gozlan; Diabé Diabira; P Chinestra; Yehezkel Ben-Ari
[NMDA receptor and long-term potentiation].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1994;317(10):885-90.
1994: C Gérard; X Langlois; Jay A Gingrich; Edith Doucet; Daniel Vergé; H K Kia; R Raisman; Henri Gozlan; Salah El Mestikawy; Michel Hamon
Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor.
Neuroscience 1994;62(3):721-39.
1994: Henri Gozlan; P Chinestra; Diabé Diabira; Yehezkel Ben-Ari
NMDA redox site modulates long-term potentiation of NMDA but not of AMPA receptors.
European journal of pharmacology 1994;262(1-2):R3-4.
1994: S Haj-Dahmane; T Jolas; AM Laporte; Henri Gozlan; A J Farré; Michel Hamon; Laurence Lanfumey
Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
European journal of pharmacology 1994;255(1-3):185-96.
1994: T Jolas; S Haj-Dahmane; E J Kidd; X Langlois; Laurence Lanfumey; C M Fattaccini; V Vantalon; AM Laporte; Joëlle Adrien; Henri Gozlan
Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1432-43.
1994: Henri Gozlan; AM Laporte; S Thibault; L E Schechter; F Bolaños; Michel Hamon
Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
Neuropharmacology 1994;33(3-4):423-31.
1993: F J Kidd; J C Levy; M Nielsen; Michel Hamon; Henri Gozlan
Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
European journal of pharmacology 1993;247(1):45-56.
1993: E J Kidd; AM Laporte; X Langlois; C M Fattaccini; C Doyen; M C Lombard; Henri Gozlan; Michel Hamon
5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals.
Brain research 1993;612(1-2):289-98.
1993: T Jolas; S Haj-Dahmane; Laurence Lanfumey; C M Fattaccini; E J Kidd; Joëlle Adrien; Henri Gozlan; B Guardiola-Lemaitre; Michel Hamon
(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1993;347(5):453-63.
1993: E J Kidd; S Haj-Dahmane; T Jolas; Laurence Lanfumey; C M Fattaccini; B Guardiola-Lemaitre; Henri Gozlan; Michel Hamon
New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
The Journal of pharmacology and experimental therapeutics 1993;264(2):863-72.
1992: L Matthiessen; G Daval; Yannick Bailly; Henri Gozlan; Michel Hamon; Daniel Vergé
Quantification of 5-hydroxytryptamine1A receptors in the cerebellum of normal and X-irradiated rats during postnatal development.
Neuroscience 1992;51(2):475-85.
1992: AM Laporte; T Koscielniak; M Ponchant; Daniel Vergé; Michel Hamon; Henri Gozlan
Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Synapse (New York, N.Y.) 1992;10(4):271-81.
1992: E Kidd; I Bouchelet de Vendegies; J C Levy; Michel Hamon; Henri Gozlan
The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system.
European journal of pharmacology 1992;211(1):133-6.
1992: N Merahi; H S Orer; AM Laporte; Henri Gozlan; Michel Hamon; Raul Laguzzi
Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat.
Neuroscience 1992;46(1):91-100.
1991: Henri Gozlan; F Saddiki-Traki; N Merahi; Raul Laguzzi; Michel Hamon
[Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats].
L'Encéphale 1991;17 Spec No 3():415-22.
1991: Marie-Christine Miquel; M B Emerit; Henri Gozlan; Michel Hamon
Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells.
Biochemical pharmacology 1991;42(7):1453-61.
1991: H S Orer; N Merahi; Anne Nosjean; Henri Gozlan; Raul Laguzzi
Sleep changes induced by the local application of 5,7-dihydroxytryptamine into the nodose ganglia and aortic denervation in the rat.
Pflügers Archiv : European journal of physiology 1991;419(1):21-4.
1991: AM Laporte; L E Schechter; F J Bolaños; Daniel Vergé; Michel Hamon; Henri Gozlan
[3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
European journal of pharmacology 1991;198(1):59-67.
1991: M B Emerit; Marie-Christine Miquel; Henri Gozlan; Michel Hamon
The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Journal of neurochemistry 1991;56(5):1705-16.
1991: F Radja; A M Laporte; G Daval; D Vergé; Henri Gozlan; Michel Hamon
Autoradiography of serotonin receptor subtypes in the central nervous system.
Neurochemistry international 1991;18(1):1-15.
1991: F J Bolaños; L E Schechter; AM Laporte; Michel Hamon; Henri Gozlan
Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Proceedings of the Western Pharmacology Society 1991;34():387-93.
1991: C M Fattaccini; Henri Gozlan; Michel Hamon
Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
Neuropharmacology 1991;30(1):15-23.
1990: L E Schechter; F J Bolaños; Henri Gozlan; Laurence Lanfumey; S Haj-Dahmane; AM Laporte; C M Fattaccini; Michel Hamon
Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
The Journal of pharmacology and experimental therapeutics 1990;255(3):1335-47.
1990: Marie-Christine Miquel; M B Emerit; F J Bolaños; L E Schechter; Henri Gozlan; Michel Hamon
Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
Journal of neurochemistry 1990;55(5):1526-36.
1990: Salah El Mestikawy; Mustapha Riad; AM Laporte; Daniel Vergé; G Daval; Henri Gozlan; Michel Hamon
Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide.
Neuroscience letters 1990;118(2):189-92.
1990: F J Bolaños; L E Schechter; Marie-Christine Miquel; M B Emerit; Jean Francois Rumigny; Michel Hamon; Henri Gozlan
Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Biochemical pharmacology 1990;40(7):1541-50.
1990: Michel Hamon; Laurence Lanfumey; Salah El Mestikawy; C Boni; Marie-Christine Miquel; F Bolaños; L Schechter; Henri Gozlan
The main features of central 5-HT1 receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(5-6):349-60.
1990: Henri Gozlan; G Daval; D Verge; U Spampinato; C M Fattaccini; M C Gallissot; Salah El Mestikawy; Michel Hamon
Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain.
Neurobiology of aging 1990;11(4):437-49.
1990: Michel Hamon; Henri Gozlan; Salah El Mestikawy; M B Emerit; F Bolaños; L Schechter
The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.
Annals of the New York Academy of Sciences 1990;600():114-29; discussion 129-31.
1990: M B Emerit; Salah El Mestikawy; Henri Gozlan; B Rouot; Michel Hamon
Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins.
Biochemical pharmacology 1990;39(1):7-18.
1990: T Koscielniak; M Ponchant; AM Laporte; Y Guminski; D Verge; Michel Hamon; Henri Gozlan
[(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1990;311(6):231-7.
1990: C M Fattaccini; F Bolaños-Jimenez; Henri Gozlan; Michel Hamon
Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain.
Neuropharmacology 1990;29(1):1-8.
1989: Henri Gozlan; L E Schechter; F Bolanos; M B Emerit; Marie-Christine Miquel; M Nielsen; Michel Hamon
Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.
European journal of pharmacology 1989;172(6):497-500.
1989: D Hoyer; Henri Gozlan; F Bolanos; L E Schechter; Michel Hamon
Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?
European journal of pharmacology 1989;171(1):137-9.
1989: Salah El Mestikawy; D Taussig; Henri Gozlan; M B Emerit; M Ponchant; Michel Hamon
Chromatographic analyses of the serotonin 5-HT1A receptor solubilized from the rat hippocampus.
Journal of neurochemistry 1989;53(5):1555-66.
1989: Michel Hamon; M C Gallissot; F Menard; Henri Gozlan; Sylvie Bourgoin; Daniel Vergé
5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord.
European journal of pharmacology 1989;164(2):315-22.
1989: Joëlle Adrien; Laurence Lanfumey; Henri Gozlan; C M Fattaccini; Michel Hamon
Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
The Journal of pharmacology and experimental therapeutics 1989;248(3):1222-30.
1988: Michel Hamon; C M Fattaccini; Joëlle Adrien; M C Gallissot; P Martin; Henri Gozlan
Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
The Journal of pharmacology and experimental therapeutics 1988;246(2):745-52.
1988: U Spampinato; Henri Gozlan; G Daval; C M Fattaccini; Michel Hamon
Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats.
European journal of pharmacology 1988;150(1-2):113-22.
1988: Henri Gozlan; M Ponchant; G Daval; D Verge; F Menard; A Vanhove; J P Beaucourt; Michel Hamon
125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
The Journal of pharmacology and experimental therapeutics 1988;244(2):751-9.
1988: Michel Hamon; Henri Gozlan
About the so-called "specific" binding of [(3)H]8-OH-DPAT to glass fiber filter.
Neurochemistry international 1988;12(1):97-9.
1988: M Ponchant; J P Beaucourt; A Vanhove; G Daval; Daniel Vergé; Michel Hamon; Henri Gozlan
[125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1988;306(4):147-52.
1987: Sylvie Bourgoin; François Cesselin; Henri Gozlan; C M Fattaccini; M A Tran; Jean-Louis Montastruc; A Rascol; Michel Hamon
Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid Met-enkephalin-like immunoreactivity in chronic-pain patients.
Clinical neuropharmacology 1987;10(5):434-42.
1987: J M Cossery; Henri Gozlan; U Spampinato; C Perdicakis; G Guillaumet; L Pichat; M Hamon
The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
European journal of pharmacology 1987;140(2):143-55.
1987: M B Emerit; Salah El Mestikawy; Henri Gozlan; J M Cossery; R Besselievre; A Marquet; M Hamon
Identification of the 5-HT1A receptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin.
Journal of neurochemistry 1987;49(2):373-80.
1987: G Daval; Daniel Vergé; A Becerril; Henri Gozlan; U Spampinato; Michel Hamon
Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1987;5(3):171-80.
1987: Henri Gozlan; M B Emerit; Salah El Mestikawy; J M Cossery; A Marquet; R Besselievre; M Hamon
Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
Journal of receptor research 1987;7(1-4):195-221.
1986: Daniel Vergé; G Daval; M Marcinkiewicz; A Patey; Salah El Mestikawy; Henri Gozlan; M Hamon
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1986;6(12):3474-82.
1986: M B Emerit; Henri Gozlan; A Marquet; M Hamon
Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
European journal of pharmacology 1986;127(1-2):67-81.
1986: Henri Gozlan; M B Emerit; M D Hall; M Nielsen; M Hamon
In situ molecular sizes of the various types of 5-HT binding sites in the rat brain.
Biochemical pharmacology 1986;35(11):1891-7.
1986: M D Hall; Henri Gozlan; M B Emerit; Salah El Mestikawy; L Pichat; M Hamon
Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
Neurochemical research 1986;11(6):891-912.
1985: D Verge; G Daval; A Patey; Henri Gozlan; Salah El Mestikawy; Michel Hamon
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype.
European journal of pharmacology 1985;113(3):463-4.
1985: M D Hall; Salah El Mestikawy; M B Emerit; L Pichat; M Hamon; Henri Gozlan
[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
Journal of neurochemistry 1985;44(6):1685-96.
1985: M B Emerit; Henri Gozlan; M D Hall; M Hamon; A Marquet
Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT.
Biochemical pharmacology 1985;34(6):883-92.
1984: M Marcinkiewicz; Daniel Vergé; Henri Gozlan; L Pichat; M Hamon
Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain.
Brain research 1984;291(1):159-63.
1983: Henri Gozlan; Salah El Mestikawy; L Pichat; J Glowinski; M Hamon
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT.
Nature 1983;305(5930):140-2.